SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950133-01-502210
Filing Date
2001-08-13
Accepted
2001-08-13 00:00:00
Documents
7
Period of Report
2001-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q w52015e10-q.htm 10-Q 90587
3 CERTIFICATE OF ELIMINATION w52015ex3-4.htm EX-3.4 3319
4 AMENDED AND RESTATED w52015ex3-5.htm EX-3.5 66834
5 FIRST AMENDMENT w52015ex10-1.htm EX-10.1 11427
6 SECOND AMENDMENT w52015ex10-2.htm EX-10.2 17818
7 FIRST AMENDMENT TO THE EXCLUSIVE LICENSE w52015ex10-3.htm EX-10.3 10367
8 SECOND AMENDMENT TO THE EXCLUSIVE LICENSE w52015ex10-4.htm EX-10.4 26707
  Complete submission text file 0000950133-01-502210.txt   229330
Mailing Address 8320 GUILFORD ROAD SUITE C 12111 PARKLAWN DR COLUMBIA MD 21046
Business Address 8320 GUILFORD RD STE C COLUMBIA MD 21046 3078543900
NOVAVAX INC (Filer) CIK: 0001000694 (see all company filings)

IRS No.: 222816046 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26770 | Film No.: 1706669
SIC: 2836 Biological Products, (No Diagnostic Substances)